Received Feb 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 2432Z | IM / LA |
Reported Symptoms: Narrative: Patient received his RSV vaccine on 10/31/2023 at the clinic. He came in on 10/28/24 and received a second dose of the RSV vaccine. RSV is only indicated as a single lifetime dose vaccine. Patient has not reported any adverse events. Other Relevant HX: Patient received his RSV vaccine on 10/31/2023 at the clinic. He came in on 10/28/24 and received a second dose of the RSV vaccine. RSV is only indicated as a single lifetime dose vaccine. Patient has not reported any adverse events. Other: N/A